Referrals
search
eNewsletter HealthPoints Sign up for our HealthPoints E-Newsletter
Department of Surgery
info@columbiasurgery.org Referrals Patient Clinician Researcher
About Us
Alumni/ JJSS
Directory
Faculty, Alpha
Staff, Alpha
Leadership
Cardiothoracic Surgery
Center for Liver Disease and Transplantation (CLDT)
General Surgery
Division of Surgical Outcomes Research (InCHOIR)
Pediatric Surgery
Plastic Surgery
Surgical Science
Vascular Surgery
Research & Information Systems
Finance Office
External Affairs
Operations & Quality Management
Office of External Affairs
Progress Reports
Ways to Give

Robert S. Brown, Jr., MD, MPH

Positions and Appointments

2008-present  Frank Cardile Professor of Medicine and Pediatrics (in Surgery)
Columbia University College of Physicians and Surgeons, New York, NY
2010-present  Medical Director, Transplant Initiative
NewYork-Presbyterianl Morgan Stanley Children's Hospital Columbia University Medical Center, New York, NY
2006-present  Director, Center for Liver Disease and Transplantation
NewYork-Presbyterian Hospital/Columbia University Medical Center, New York, NY
2000-present  Attending Physician
NewYork-Presbyterian Hospital/Columbia University Medical Center, New York, NY

Clinical Specialties

Medical support for pre- and post-operative transplant recipients
Use of bioartificial liver support devices
Living donor liver transplantation
Treatment of Hepatitis B and C

Education and Training

1996  MPH
Graduate School of Public Health, University of California Berkeley, Berkeley, CA
1992-1995  Fellow in Gastroenterology and Hepatology
University of California San Francisco,
San Francisco, CA
1991-1992  Senior Assistant Resident in Medicine
Beth Israel Hospital, Boston, MA
1990-1991  Junior Assistant Resident in Medicine
Beth Israel Hospital, Boston, MA
1989-1990   Intern in Medicine
Beth Israel Hospital, Boston, MA
1989   MD, alpha omega alpha
New York University, New York, NY
1985  BA, cum laude
Harvard College, Cambridge, MA

Board Certifications

Board Certified in Transplant Hepatology, 2010
Board Certified in Gastroenterology, 1995
Board Certified in Internal Medicine, 1992
National Board of Medical Examiners Diplomate, 1990

Professional Experience

2006-2010  Chief, Division of Abdominal Organ Transplantation
NewYork-Presbyterian Hospital/Columbia University Medical Center, New York, NY
2008-2009  Frank Cardile Associate Professor of Medicine and Pediatrics (in Surgery)
Columbia University College of Physicians and Surgeons, New York, NY
2000-2007  Associate Professor of Medicine and Pediatrics (in Surgery)
Columbia University College of Physicans and Surgeons, New York, NY
2005-2006  Chief, Division of Hepatobiliary and Abdominal Transplant Surgery
NewYork-Presbyterian Hospital/Columbia University Medical Center, New York, NY
1998-2005  Medical Director, Center for Liver Disease and Transplantation
NewYork-Presbyterian Hospital/Columbia University Medical Center, New York, NY
1997-1998  Assistant Professor of Pediatrics
University of North Carolina, Chapel Hill, NC
1997-1998  Assistant Professor of Epidemiology
School of Public Health, University of North Carolina, Chapel Hill, NC
1996-1998  Medical Director of Liver Transplantation
University of North Carolina, Chapel Hill, NC
1996-1998  Assistant Professor of Medicine
University of North Carolina, Chapel Hill, NC
1994-1996  Clinical Instructor in Medicine
University of California San Francisco,
San Francisco, CA

Professional Honors

Senior Attending Teaching Award, 2009--Awarded by NewYork-Presbyterian Hospital/Columbia University Medical Center Department of Medicine Housestaff Office

Young Investigator Award, American Society of Transplant Physicians, 1996

Professional Societies and Committees

Fellow American Gastroenterological Association, 2009

American Gastroenterological Association Practice Management & Economics Committee, 2008

Fellow, American College of Physicians, 2000

Fellow, American College of Gastroenterology, 2001

United Network for Organ Sharing (UNOS) Living Donor Committee, Chair, 2006-2007

Ex. Officio, United Network for Organ Sharing (UNOS) Living Donor Committee, 2008-2009

United Network for Organ Sharing (UNOS) ad hoc Living Donor Committee, Chair Ethics Subcommittee, 2002-2009

American Association for the Study of Liver Diseases, Clinical Research Committee

American Liver Foundation

American Society of Gastrointestinal Endoscopists

American Society of Transplant Physicians

American Society of Transplant Surgeons

American Society of Transplantation

International Liver Transplantation Society

Physician Volunteers for the Arts


Research Abstracts


Please click abstract title to read full text.

New Data from Largest U.S. Hepatitis C Trial Provide Insights Into Optimizing Treatment for Patient Populations Traditionally Considered Difficult to Treat

Peer-Reviewed Articles

Campsen J, Zimmerman M, Trotter J, Hong J, Freise C, Brown R Jr.*, Cameron A, Ghobrial M, Kam I, Busuttil R, Saab S, Holt, Emond J.C., Stiles J, Lukose T, Chang M.S, Klintmalm G. Multicenter Review of Liver Transplant for Hepatitis B Related Liver Disease: Disparities in Gender and Ethnicity (submitted)

Brown R, Jacobson I. Tenofovir Disoproxil Fumarate in Patients with Lamivudine-Resistant Chronic Hepatitis B Virus Infection: A Review. Am Jour of Gastoenterol (submitted)

Kulik L.M., Fisher R.A., Rodrigo D.R., Brown R.S.*, Freise C.E., Shaked A., Everhart J.E., Everson G.T., Hong J.C., Hayashi P.H., Berg C.L., Lok A.S.F., and the A2ALL Study Group. Outcomes of Living and Deceased Donor Liver Transplantation Recipients with Hepatocellular Carcinoma: Results of the A2ALL Cohort
Am J Transplant 2012 (in press)

Brown RS Jr.*, Verna EC, Pereira MR, Tilson HH, Aguilar C, Leu CS, Buti M, Fagan EA. Hepatitis B virus and human immunodeficiency virus drugs in pregnancy: Findings from the Anti-retroviral Pregnancy Registry. J Hepatol. 2012 Nov;57(5):953-9. doi: 10.1016/j.jhep.2012.06.031. Epub 2012 Jul 2.

Verna EC, Abdelmessih R, Salomao MA, Lefkowitch J, Moreira RK, Brown RS Jr.*, Cholestatic hepatitis C following liver transplantation: An outcome-based histological definition, clinical predictors and prognosis. Liver Transpl. 2012 Oct 18. doi: 10.1002/lt.23559. [Epub ahead of print]

Moreira RK, Salomao M, Verna EC, Brown RS Jr.*, Lefkowitch JH. The Hepatitis Aggressiveness Score (HAS): A Novel Classification System for Post-Liver Transplantation Recurrent Hepatitis C. Am J Surg Pathol. 2012 Oct 10. [Epub ahead of print]

Gordon FD, Kwo P, Ghalib R, Crippin J, Vargas HE, Brown KA, Schiano T, Chaudhri E, Pedicone LD, Brown RS Jr.*, Peginterferon-α-2b and ribavirin for hepatitis C recurrencepostorthotopic liver transplantation. J Clin Gastroenterol. 2012 Sep;46(8):700-8.

Siegel A, Lim A. E, Wang S, Brubaker W, Hidalgo D. H, Goyal, Jacobson S. J, Hershman L. D, Verna E, Zaretsky J, Halazun K, Dove L, Brown RS Jr.*, Neugut I. A, Kato T, Remotti H, Coppleson J. Y, and Emond C. J Diabetes, Body Mass Index, and Outcomes in Hepatocellular Carcinoma Patients Undergoing Liver Transplantation. Transplantation 2012 Sep 15;94(5):539-43

Sher L, Jennings L, Rudich S, Alexopoulos SP, Netto G, Teperman L, Kinkhabwala M, Brown RS Jr.*, Pomfret E, Klintmalm G; HCV-3 Study Group. Results of live donor liver transplantation in patients with hepatitic C virus infection: the HCV 3 trial experience. Clin Transplant. 2012 May-Jun;26(3):502-9. doi: 10.1111/j.1399-0012.2011.01561.x. Epub 2011 Dec 12.

Saxena V, Lai JC, O'Leary JG, Verna EC, Brown RS Jr.*, Stravitz RT, Trotter JF, Krishnan K, Terrault NA; Consortium to Study Health Outcomes in HCV Liver Transplant Recipients. Recipient-donor race mismatch for African American liver transplant patients with chronic hepatitis C. Liver Transpl. 2012 May; 18(5): 524-31. doi: 10.1002/lt.22461.

Lai JC, O'Leary JG, Trotter JF, Verna EC, Brown RS Jr.*, Stravitz RT, Duman JD, Forman LM, Terrault NA; Consortium to Study Health Outcomes in HCV Liver Transplant Recipients (CRUSH-C). Risk of advanced fibrosis with grafts from hepatitis C antibody-positive donors: a multicenter cohort study. Liver Transpl. 2012 May;18(5):532-8. doi: 10.1002/lt.23396.

Verna EC, Valadao R, Farrand E, Pichardo EM, Lai JC, Terrault NA, Brown RS Jr.*, Effects of ethnicity and socioeconomic status on survival and severity of fibrosis in liver transplant recipients with hepatitis C virus. Liver Transpl. 2012 Apr;18(4):461-7. doi: 10.1002/lt.23376.

Chang, M. S., S. K. Olsen, E. M. Pichardo, S. Heese, J. B. Stiles, R. Abdelmessih, E. C. Verna, J. V. Guarrera, J. C. Emond, and R. S. Brown, Jr. 2012. Prevention of de novo hepatitis B with adefovir dipivoxil in recipients of liver grafts from hepatitis B core antibody-positive donors. Liver Transpl 18(7):834-838.

Everson, G. T., N. A. Terrault, A. S. Lok, D. R. Rodrigo, R. S. Brown, Jr., S. Saab, M. L. Shiffman, A. M. Al-Osaimi, L. Kulik, B. W. Gillespie, and J. E. Everhart. 2012. A randomized controlled trial of pretransplant antiviral therapy to prevent recurrence of hepatitis c after liver transplantation. Hepatology.

Fox, A. N. and R. S. Brown, Jr. 2012. Is the patient a candidate for liver transplantation? Clin Liver Dis 16(2):435-448.

Gonda, T. A., M. P. Glick, A. Sethi, J. M. Poneros, W. Palmas, S. Iqbal, S. Gonzalez, S. V. Nandula, J. C. Emond, R. S. Brown, V. V. Murty, and P. D. Stevens. 2012. Polysomy and p16 deletion by fluorescence in situ hybridization in the diagnosis of indeterminate biliary strictures. Gastrointest Endosc 75(1):74-79.

Gordon, F. D., P. Kwo, R. Ghalib, J. Crippin, H. E. Vargas, K. A. Brown, T. Schiano, E. Chaudhri, L. D. Pedicone, and R. S. Brown, Jr. 2012. Peginterferon-alpha-2b and Ribavirin for Hepatitis C Recurrence Postorthotopic Liver Transplantation. J Clin Gastroenterol 46(8):700-708.

Jacobson, I. M., F. Poordad, R. S. Brown, Jr., P. Y. Kwo, K. R. Reddy, and E. Schiff. 2012. Standardization of terminology of virological response in the treatment of chronic hepatitis C: panel recommendations. Journal of viral hepatitis 19(4):236-243.

Kato, T., S. J. Lobritto, A. Tzakis, Y. Raveh, P. R. Sandoval, M. Martinez, L. Granowetter, A. Armas, R. S. Brown, Jr., and J. Emond. 2012. Multivisceral ex vivo surgery for tumors involving celiac and superior mesenteric arteries. Am J Transplant 12(5):1323-1328.

Kluger, M. D., J. V. Guarrera, S. K. Olsen, R. S. Brown, Jr., J. C. Emond, and D. Cherqui. 2012. Safety of Blood Group A2-to-O Liver Transplantation: An Analysis of the United Network of Organ Sharing Database. Transplantation 94(5):526-531.

Verna, E. C., R. S. Brown, E. Farrand, E. M. Pichardo, C. S. Forster, D. A. Sola-Del Valle, S. H. Adkins, M. E. Sise, J. A. Oliver, J. Radhakrishnan, J. M. Barasch, and T. L. Nickolas. 2012a. Urinary neutrophil gelatinase-associated lipocalin predicts mortality and identifies acute kidney injury in cirrhosis. Dig Dis Sci 57(9):2362-2370.

Klintmalm GB, Davis GL, Teperman L, Netto GJ, Washburn K, Rudich SM, Pomfret EA, Vargas HE, Brown R*, Eckhoff D, Pruett TL, Roberts J, Mulligan DC, Charlton MR, Heffron TG, Ham JM, Douglas DD, Sher L, Baliga PK, Kinkhabwala M, Koneru B, Abecassis M, Millis M, Jennings LW, Fasola CG. A randomized, multicenter study comparing steroid-free immunosuppression and standard immunosuppression for liver transplant recipients with chronic hepatitis C. Liver Transpl. 2011 Dec;17(12):1394-403. doi: 10.1002/lt.22417.

Lai JC, Verna EC, Brown RS Jr.*, O'Leary JG, Trotter JF, Forman LM, Duman JD, Foster RG, Stravitz RT, Terrault NA; Consortium to Study Health Outcomes in HCV Liver Transplant Recipients (CRUSH-C). Hepatitis C virus-infected women have a higher risk of advanced fibrosis and graft loss after liver transplantation than men. Hepatology. 2011 Aug;54(2):418-24. doi: 10.1002/hep.24390. Epub 2011 Jun 23.

Liaw Y, Raptopoulou-Gigi M, Cheinquer H, Sarin SK, Tanwandee T, Leung N, Peng CY, Myers RP, Brown RS Jr.*, Jeffers L, Tsai N, Bialkowska J, Tang S, Beebe S, Cooney E. Efficacy and Safety of Entecavir versus Adefovir in Chronic Hepatitis B Patients with Hepatic Decompensation: A Randomized Open-Label Study Hepatology. 2011 Jul;54(1):91-100. doi: 10.1002/hep.24361.

Verna EC, Farrand ED, Elnaggar AS, Pichardo EM, Balducci A, Emond JC, Guarrera JV, Brown RS Jr.*, Basiliximab induction and delayed calcineurin inhibitor initiation in liver transplant recipients with renal insufficiency. Transplantation. 2011 Jun 15;91(11):1254-60.

Sher L, Jennings L, Rudich S, Netto G, Teperman L, Kinkhabwala M, Brown RS Jr., Pomfret E, Klintmalm G, HCV-3 Study Group. The Impact of Live Donor Liver Transplantation on Hepatitis C Recurrence: The HCV 3 Trial Experience. (In oress)

Liaw Y, Raptopoulou-Gigi M, Cheinquer H, Sarin SK, Tanwandee T, Leung N, Peng CY, Myers RP, Brown RS Jr., Jeffers L, Tsai N, Bialkowska J, Tang S, Beebe S, Cooney E. Efficacy and Safety of Entecavir versus Adefovir in Chronic Hepatitis B Patients with Hepatic Decompensation: A Randomized Open-Label Study (submitted)

Trotter JF, Gillespie BW, Terrault NA, Abecassis MM, Merion RM, Brown RS Jr, Olthoff KM, Hayashi PH, Berg CL, Fisher RA, Everhart JE, and the Adult-to-Adult Living Donor Liver Transplantation Cohort Study Group. Laboratory Test Results After Living Liver Donation in the Adult-to-Adult Living Donor Liver Transplantation Cohort Study. Liver Transpl 17:409-417, 2011

Hu, K. Q., B. Freilich, R. S. Brown, C. Brass, and I. M. Jacobson. Impact of Hispanic or Asian ethnicity on the treatment outcomes of chronic hepatitis C: results from the WIN-R trial. J Clin Gastroenterol 45(8):720-726, 2011

Afdhal, N. H., B. R. Bacon, and R. S. Brown, Jr. 2011. Chronic hepatitis B: integrating long-term treatment data and strategies to improve outcomes in clinical practice. Gastroenterology & hepatology 7(3 Suppl 4):1-16.

Berg, C. L., R. M. Merion, T. H. Shearon, K. M. Olthoff, R. S. Brown, Jr., T. B. Baker, G. T. Everson, J. C. Hong, N. Terrault, P. H. Hayashi, R. A. Fisher, and J. E. Everhart. 2011. Liver transplant recipient survival benefit with living donation in the model for endstage liver disease allocation era. Hepatology 54(4):1313-1321.

Brown, R. S., Jr. 2011. Transplantation for alcoholic hepatitis--time to rethink the 6-month "rule". N Engl J Med 365(19):1836-1838.

Guarrera, J. V., S. D. Henry, S. W. Chen, T. Brown, E. Nachber, B. Arrington, J. Boykin, B. Samstein, R. S. Brown, Jr., J. C. Emond, and H. T. Lee. 2011. Hypothermic machine preservation attenuates ischemia/reperfusion markers after liver transplantation: preliminary results. J Surg Res 167(2):e365-373.

Sanyal, A., Z. M. Younossi, N. M. Bass, K. D. Mullen, F. Poordad, R. S. Brown, R. P. Vemuru, M. Mazen Jamal, S. Huang, K. Merchant, E. Bortey, and W. P. Forbes. 2011. Randomised clinical trial: rifaximin improves health-related quality of life in cirrhotic patients with hepatic encephalopathy - a double-blind placebo-controlled study. Aliment Pharmacol Ther 34(8):853-861.

Terrault NA, Tran TT, Schiff E, McGuire BM, Brown RS Jr., Tupper R., Ramanathan S, Enejosa J, Zhong L, Zong J – for the Study 531 Team. Pharmacokinetics of Tacrolimus Co-administered with Adefovir Dipivoxil to Liver Transplant Recipients (submitted)

Hassanein T, Blei AT, Perry W, Hilsabeck R, Stange J, Larsen FS, Brown RS Jr., Caldwell S, McGuire B, Nevens F, Fontana R. Performance of the Hepatic Encephalopathy Scoring Algorithm in a Clinical Trial of Patients with Cirrhosis and Severe Hepatic Encephalopathy. Am Jour of Gastroenterol (submitted)

Hoofnagle JH, Wahed AS, Brown RS Jr., Howell CD, Belle SH for the Virahep-C Study Group. Early Changes in Hepatitis C Viral Levels in Response to Peginterferon and Ribavirin in African American and Caucasian American Patients with Chronic hepatitis C, Genotype 1 Infection. (submitted)

Yu J, Neugut A, Wang S, Jacobson J, Ferrante L, Khungar V, Lim E, Hershman D, Brown R, Siegel A. Racial and Insurance Disparities in the Receipt of Transplant among Patients with Hepatocellular Carcinoma (in press)

Peng T, Zamanian R, Krowka M, Benza R, Roberts K, Taichman D, Rybak D, Trotter J, Brown RS, Fallon M, Kawut S. Plasma Levels of S100A4 in Portopulmonary Hypertension. BiOMARKERS (in press)

Roberts KE, Fallon MB, Krowka MJ, Benza RL, Knowles JA, Badesch DB, Brown RS Jr., Taichman DB, Trotter JF, Zachs S, Horn EM, Kawut SM for the PVCLD Study Group. Serotonin Transporter Polymorphisms in Patients with Portopulmonary Hypertension. Chest (in press)

Rybak D, Fallon MB, Krowka MJ, Brown RS, Reinen J, Stadheim L, Faulk D, Nielsen C, Al-Naamani N, Roberts K, Zacks S, Perry T, Trotter J, Kawut SM. Risk Factors and Impact of Chronic Obstructive Pulmonary Disease in Candidates for Liver Transplantation. Liver Transpl (in press)

Dove LM, Rosen RC, Ramcharran D, Wahed AS, Belle SH, Brown RS, Hoofnagle JH for the Virahep-C Study Group. Decline in Male Sexual Desire, Function and Satisfaction During and After Antiviral Therapy for Chronic Hepatitis C.

Stein EM, Cohen A, Freeby M, Rogers H, Kokolus S, Scott V, Mancini D, Restaino S, Brown R, McMahon DJ, Shane E. Severe Vitamin D Deficiency among Heart and Liver Transplant Recipients. Clin Transplant 2009 DOI: 10.1111/J.1399-0012

Verna EC, DeMartin E, Burra P, Neri D, Gaglio PJ, Emond JC, Brown RS Jr. The Impact of Hepatitis C and Biliary Complications on Patient and Graft Survival Following Liver Transplantation. Am Jour of Transpl 2009, 9:1398-1405

Roberts KE, Fallon MB, Krowka MJ, Brown RS Jr., Trotter JF, Tighiouart H, Knowles JA, Babinowitz D, Benza RL, Badesch DB, Taichman DB, Horn EM, Zacks S, Kaplowitz N, Kawut SM for the PVCLD Study Group. Genetic Risk Factors for Portopulmonary Hypertension in Patients with Advanced Liver Disease. 2009 AmJ Resp Crit Care Med Vol 179 pp835-842.

Lai, JC, Pichardo, EM, Emond JC, Brown RS Jr. Resource Utilization of Living Donor Versus Deceased Donor Liver Transplantation is Similar at an Experienced Transplant Center. Am Jour of Trans 2009; 9: 586-591

Lai JC, Lebwohl B, Montero A, Brown RS Jr*. The Specialized Housestaff Service Model: A Novel Housestaff Educational Model for Quaternary-Care Patients at an Academic Medical Center. Academic Medicine February 2009 Vol 84;2:206-11

Rana A, Hardy MA, Halazun KJ, Woodland DC, Ratner LE, Samstein B, Guarrera JV, Brown RS Jr, Emond JC. Survival Outcomes Following Liver Transplantation (SOFT) score: A novel method to predict patient survival following liver transplantation. Am J Transplant 2008;8:2537-46.

Siegel, AB, Cohen E, Ocean A, Lehrer D, Goldenberg A, Knox JJ, Chen H, Garvey SC, Weinberg A, Mandeli J, Christos P, Mazumdar M, Brown RS Jr., Popa E, Jin D, Rafii S, Schwartz J. A Phase II Trial Evaluating the Clinical and Biological Effects of Bevacizumab in Unresectable Hepatocellular Carcinoma. J Clin Oncol 2008;26:2992-8.

Kawut SM, Krowka MJ, Trotter JF, Roberts KE, Benza RL, Badesch DB, Taichman DB, Horn EM, Zacks S, Kaplowitz N, Brown RS, Fall MB. Clinical Risk Factors for Portopulmonary Hypertension. Hepatology 2008;48:196-203.

Siegel AB, McBride R, El-Serag H, Zablotska L, Hershman D, Brown RS Jr., Neugut AI. The Risk of hepatocellular Carcinoma in Patients with Previous Malignancy. Presented, GI ASCO 2007. Cancer Invest 2008;26:511-5.

Brown RS Jr* Live Donors in Liver Transplantation. Gastroenterology 2008;134:1802-1813

Fallon MB, Krowka MJ, Brown RS, Trotter JF, Zacks S, Roberts KE, Shah VH, Kaplowitz N, Forman L, Wille K, Kawut SM for the PVCLD Study Group. Impact of Hepatopulmonary Syndrome on Quality of Life and Survival in Liver Transplant Candidates. Gastroenterology 2008;135:1168-75.

Siegel AB, McBride RB, El-Serag HB, Hershman DL, Brown RS, Jr., Renz JF, Emond JC, Neugut AI. Racial Disparities in Utilization of Liver Transplantation for Hepatocellular Carcinoma in the United States 1998-2002. Am J Gastroenterol 2008;103:120-7

Haskal ZJ, Brown RS Jr.* Role of Biliary Stress Manometry after Biliary Stricture Dilation in Living Donor Liver Transplant Recipients. J Vasc Interv Radiol 2008; 19:216-219

Afdhal N, McHutchinson J, Brown R, Jacobson I, Manns M, Poordad F, Weksler B, Esteban R. Thrombocytopenia Associated with Chronic Liver Disease. J Hepatol 2008;48:1000-07

Hassanein TI, Tofteng F, Brown RS Jr, McGuire B, Lynch P, Mehta R, Larsen FS, Gorbein J, Stange J, Blei AT. Randomized Controlled Study of Extracorporeal Albumin Dialysis for Hepatic Encepholopathy in Advanced Cirrhosis. Hepatology 2007;46:1853-62

Jakab SS, West AB, Meighan DM, Brown RS Jr, Hale WB. Mycophenolate mofetil for drug-induced vanishing bile duct syndrome. World J Gastroenterol. 2007 Dec 7; 13(45):6087-6089.

Brown RS Jr. Steroids in recurrent hepatitis C following liver transplantation: Pitfall or panacea? J Hepatol. 2007 Dec; 47(6):741-3. Epub 2007 Oct 8.

Weisberg IS, Brown RS Jr, Sigal SH. Hepatitis B and end-stage liver disease. Clin Liver Dis. 2007 Nov; 11(4):893-916.

Hassanein TI, Tofteng F, Brown RS Jr, McGuire B, Lynch P, Mehta R, Larsen FS, Gornbein J, Stange J, Blei AT. Randomized controlled study of extracorporeal albumin dialysis for hepatic encephalopathy in advanced cirrhosis. Hepatology. 2007 Nov 1.

Jacobson IM, Brown RS Jr, McCone J, Black M, Albert C, Dragutsky MS, Siddiqui FA, Hargrave T, Kwo PY, Lambiase L, Galler GW, Araya V, Freilich B, Harvey J, Griffel LH, Brass CA; WIN-R Study Group. Impact of weight-based ribavirin with peginterferon alfa-2b in African Americans with hepatitis C virus genotype 1. Hepatology. 2007 Oct; 46(4):982-90.

Jacobson IM, Brown RS Jr, Freilich B, Afdhal N, Kwo PY, Santoro J, Becker S, Wakil AE, Pound D, Godofsky E, Strauss R, Bernstein D, Flamm S, Pauly MP, Mukhopadhyay P, Griffel LH, Brass CA; WIN-R Study Group. Peginterferon alfa-2b and weight-based or flat-dose ribavirin in chronic hepatitis C patients: a randomized trial. Hepatology. 2007 Oct; 46(4):971-81.

Guarrera JV, Alkofer BJ, Feirt N, Sandoval R, Samstein B, Smith ET Jr, Marshman D, Cogswell C, Vannatta J, Brown RS Jr, Emond JC, Renz JF. Discovery of diffuse biliary microhamartomas during liver procurement. Liver Transpl. 2007 Oct; 13(10):1470-1.

Siegel AB, McBride R, El-Serag H, Hershman D, Brown RS Jr, Renz J, Neugut A. Racial disparities in utilization of liver transplantation for hepatocellular carcinoma. Presentation, GI ASCO 2006, accepted, A J Gastroenterol.

Hernandez L, Johnson TC, Naiyer AJ, Kryszak D, Ciaccio EJ, Min A, Bodenheimer HC Jr, Brown RS Jr, Fasano A, Green PH. Chronic Hepatitis C Virus and Celiac Disease, is there an Association? Dig Dis Sci. 2007 Jun 5.

Fisher RA, Kulik LM, Freise CE, Lok AS, Shearon TH, Brown RS Jr, Ghobrial RM, Fair JH, Olthoff KM, Kam I, Berg CL; A2ALL Study Group. Hepatocellular carcinoma recurrence and death following living and deceased donor liver transplantation. Am J Transplant. 2007 Jun; 7(6):1601-8.

McHutchison JG, Manns MP, Brown RS Jr, Reddy KR, Shiffman ML, Wong JB. Strategies for managing anemia in hepatitis C patients undergoing antiviral therapy. Am J Gastroenterol. 2007 Apr; 102(4):880-9.

Terrault NA, Shiffman ML, Lok AS, Saab S, Tong L, Brown RS Jr, Everson GT, Reddy KR, Fair JH, Kulik LM, Pruett TL, Seeff LB; A2ALL Study Group. Outcomes in hepatitis C virus-infected recipients of living donor vs. deceased donor liver transplantation. Liver Transpl. 2007 Jan; 13(1):122-9.

Brown RS Jr. Customizing treatment to patient populations. Nat Clin Pract Gastroenterol Hepatol. 2007 Jan; 4 Suppl 1:S3-9.

Olsen SK, Brown RS Jr. Hepatitis B treatment: Lessons for the nephrologist. Kidney Int. 2006 Dec;70(11):1897-904. Epub 2006 Oct 4.

Verna EC, Brown RS Jr. Hepatitis C virus and liver transplantation. Clin Liver Dis. 2006 Nov; 10(4):919-40.

Lefkowitch JH, Lobritto SJ, Brown RS Jr, Emond JC, Schilsky ML, Rosenthal LA, George DM, Cairo MS. Ground-glass, polyglucosan-like hepatocellular inclusions: A "new" diagnostic entity. Gastroenterology. 2006 Sep; 131(3):713-8.

Brown RS Jr. Asymptomatic liver mass. Gastroenterology. 2006 Aug; 131(2):619-23.

Brown RS Jr. Evaluating the evidence from clinical trials in chronic hepatitis C. J Viral Hepat. 2006 May; 13 Suppl 1:15-25.

Gaglio PJ, Brown RS Jr. Who should treat liver transplant patients? The transplant hepatologist or the gastroenterologist? Part I: the transplant hepatologist. J Hepatol. 2006 Apr; 44(4):655-7.

Dickson RC, Terrault NA, Ishitani M, Reddy KR, Sheiner P, Luketic V, Soldevila-Pico C, Fried M, Jensen D, Brown RS Jr, Horwith G, Brundage R, Lok A. Protective antibody levels and dose requirements for IV 5% Nabi Hepatitis B immune globulin combined with lamivudine in liver transplantation for hepatitis B-induced end stage liver disease. Liver Transpl. 2006 Jan; 12(1):124-33.

Moss J, Lapointe-Rudow D, Renz JF, Kinkhabwala M, Dove LM, Gaglio PJ, Emond JC, Brown RS Jr. Select utilization of obese donors in living donor liver transplantation: implications for the donor pool. Am J Transplant. 2005 Dec; 5(12):2974-81.

Jacobson IM, Gonzalez SA, Ahmed F, Lebovics E, Min AD, Bodenheimer HC Jr, Esposito SP, Brown RS Jr, Bräu N, Klion FM, Tobias H, Bini EJ, Brodsky N, Cerulli MA, Aytaman A, Gardner PW, Geders JM, Spivack JE, Rahmin MG, Berman DH, Ehrlich J, Russo MW, Chait M, Rovner D, Edlin BR. A randomized trial of pegylated interferon alpha-2b plus ribavirin in the retreatment of chronic hepatitis C. Am J Gastroenterol. 2005 Nov; 100(11):2453-62.

Verna EC, Hunt KH, Renz JF, Rudow DL, Hafliger S, Dove LM, Kinkhabwala M, Emond JC, Brown RS Jr. Predictors of candidate maturation among potential living donors. Am J Transplant. 2005 Oct; 5(10):2549-54.

Rudow DL, Brown RS Jr. Role of the independent donor advocacy team in ethical decision making. Prog Transplant. 2005 Sept; 15(3):298-302.

Brown RS Jr. MARS preconditioning for living donor liver transplantation: panacea or placebo? Liver Int. 2005 Aug; 25(4):692-5.

Rudow DL, Chariton M, Sanchez C, Chang S, Serur D, Brown RS Jr. Kidney and liver living donors: a comparison of experiences. Prog Transplant. 2005 Jun; 15(2):185-91.

Herrine SK, Brown RS Jr, Bernstein DE, Ondovik MS, Lentz E, Te H. Peginterferon alpha-2a combination therapies in chronic hepatitis C patients who relapsed after or had a viral breakthrough on therapy with standard interferon alpha-2b plus ribavirin: a pilot study of efficacy and safety. Dig Dis Sci. 2005 Apr; 50(4):719-26.

Sterling RK, Brown RS Jr, Hofmann CM, Luketic VA, Stravitz RT, Sanyal AJ, Contos MJ, Mills AS, Smith V, Shiffman ML. The Spectrum of Chronic Hepatitis C Virus Infection in the Virginia Correctional System: Development of a Strategy for the Evaluation and Treatment of Inmates with HCV. Am J Gastroenterol. 2005 Feb; 100(2):313-21.

Books

Brown Jr., Robert S., Guest Editor, Gastrointestinal Endoscopy – Clinics of North America, W.B. Saunders, Volume II, Number 1, January 2000.

Case Reports

Yee HF Jr, Brown RS Jr, Ostroff JW. Fatal Clostridium difficile enteritis following total abdominal colectomy. J Clin Gastro 1995; 22: 45-7.

Brown RS Jr, Farraye F, Peppercorn MA, Glotzer DG, Antonioli D, Taylor G. Carcinoid tumor of the esophagus. J Clin Gastro 1994; 19: 338-9.

(Visit PubMed to view this faculty member's most recent articles.)






Address:
NewYork-Presbyterian Hospital/Columbia
PH Room PH 14, 105
622 West 168th St
New York, NY   10032

Phone: 212-305-0914
Fax: 212-305-4343


rb464@columbia.edu


Podcasts and Web Presentations
Podcasts and Web Presentations

     Contact Us About Us  Ways to Give Site Map Disclaimer Find a Physician Patient Forms Intranet
Columbia University Medical Center NewYork-Presbyterian Hospital